These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37243382)

  • 1. A single-blinded, randomized controlled trial of standard versus higher dose carboplatin-based intravenous chemotherapy for group D and E retinoblastoma.
    Roy PS; Muhammed S; Singh U; Gowravajhala S; Jain R; Trehan A; Bansal D
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30444. PubMed ID: 37243382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma.
    Shields CL; Jorge R; Say EA; Magrath G; Alset A; Caywood E; Leahey AM; Jabbour P; Shields JA
    Asia Pac J Ophthalmol (Phila); 2016; 5(2):97-103. PubMed ID: 26765038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
    Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial.
    Wen X; Fan J; Jin M; Jiang H; Li J; Han M; Zhang C; He X; Luo Y; Yang J; Zhou M; Tan J; Yang X; Ji X; Zhang J; Zhao J; Jia R; Fan X
    Lancet Child Adolesc Health; 2023 Sep; 7(9):613-620. PubMed ID: 37536351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
    Shields CL; Bas Z; Tadepalli S; Dalvin LA; Rao R; Schwendeman R; Lally SE; Shields JA; Shah A; Leahey A
    Br J Ophthalmol; 2020 Nov; 104(11):1548-1555. PubMed ID: 32051141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
    Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
    Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
    Rojanaporn D; Kaliki S; Bianciotto CG; Iturralde JC; Say EA; Shields CL
    Arch Ophthalmol; 2012 May; 130(5):585-90. PubMed ID: 22652844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
    Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
    J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).
    Jubran RF; Villablanca JG; Krailo M; Piao J; Huang L; Murphree AL; O'Brien J; Gombos D; Shields CL; Meadows A; Chintagumpala M
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28502. PubMed ID: 32589362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.